S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
Biden, Dems prevail as Senate OKs $1.9T virus relief bill
pixel
Highlights of the $1.9T COVID bill nearing final passage
The Latest: Senate OKs $1.9T COVID bill, nears final passage
Escalating violence ups pressure for Myanmar sanctions
pixel
Chinese exports surge as global demand recovers from virus
Russia scores points with vaccine diplomacy, but snags arise
This Is the Maximum Number of Hours You Should Work to Avoid Stress
pixel
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
Biden, Dems prevail as Senate OKs $1.9T virus relief bill
pixel
Highlights of the $1.9T COVID bill nearing final passage
The Latest: Senate OKs $1.9T COVID bill, nears final passage
Escalating violence ups pressure for Myanmar sanctions
pixel
Chinese exports surge as global demand recovers from virus
Russia scores points with vaccine diplomacy, but snags arise
This Is the Maximum Number of Hours You Should Work to Avoid Stress
pixel
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
Biden, Dems prevail as Senate OKs $1.9T virus relief bill
pixel
Highlights of the $1.9T COVID bill nearing final passage
The Latest: Senate OKs $1.9T COVID bill, nears final passage
Escalating violence ups pressure for Myanmar sanctions
pixel
Chinese exports surge as global demand recovers from virus
Russia scores points with vaccine diplomacy, but snags arise
This Is the Maximum Number of Hours You Should Work to Avoid Stress
pixel
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
Biden, Dems prevail as Senate OKs $1.9T virus relief bill
pixel
Highlights of the $1.9T COVID bill nearing final passage
The Latest: Senate OKs $1.9T COVID bill, nears final passage
Escalating violence ups pressure for Myanmar sanctions
pixel
Chinese exports surge as global demand recovers from virus
Russia scores points with vaccine diplomacy, but snags arise
This Is the Maximum Number of Hours You Should Work to Avoid Stress
pixel
Log in
NYSEARCA:XBI

SPDR S&P Biotech ETF Stock Forecast, Price & News

$138.77
+3.34 (+2.47 %)
(As of 03/5/2021 12:00 AM ET)
Add
Today's Range
$128.44
Now: $138.77▼
$138.85
50-Day Range
$135.43
MA: $156.26▼
$173.99
52-Week Range
$62.94
Now: $138.77▼
$174.79
Volume13.04 million shs
Average Volume6.04 million shs
Market Capitalization$6.95 billion
P/E RatioN/A
Dividend Yield0.21%
BetaN/A
SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index. SSgA Funds Management, Inc. is the Fund's investment advisor.

Basic Details

Issuer SSgA
Fund NameSPDR S&P Biotech ETF
Tax ClassificationRegulated Investment Company
SymbolNYSEARCA:XBI
Inception Date1/31/2006
Fund ManagerMichael Feehily, Karl Schneider, Raymond Donofrio
Webwww.spdrs.com
Phone+1-866-7872257

Fund Focus

Asset ClassEquity
BenchmarkS&P Biotech Index
CategorySector
FocusHealth Care
Development LevelDeveloped Markets
RegionNorth America

Fund Statistics

Assets Under Management$5.93 billion
Average Daily Volume$4.83 million
Discount/Premium0.14%

ETF Expenses

Management Fee0.35%
Other Expenses0.00%
Total Expenses0.35%
Fee Waiver0.00%
Net Expenses0.35%

Administrator, Advisor and Custodian

AdministratorSSgA Funds Management, Inc.
AdvisorSSgA Funds Management, Inc.
CustodianState Street Bank and Trust Company
DistributorState Street Global Advisors Funds Distributors, LLC
Transfer AgentState Street Bank and Trust Company
Trustee
Lead Market MakerVirtu Financial

Geographic Exposure of XBI

Currency Exposure of XBI

Sector Exposure of XBI

Industry Exposure of XBI

$138.77
+3.34 (+2.47 %)
(As of 03/5/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive XBI News and Ratings via Email

Sign-up to receive the latest news and ratings for XBI and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











SPDR S&P Biotech ETF (NYSEARCA:XBI) Frequently Asked Questions

What stocks does MarketBeat like better than SPDR S&P Biotech ETF?

Wall Street analysts have given SPDR S&P Biotech ETF a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but SPDR S&P Biotech ETF wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

How has SPDR S&P Biotech ETF's stock price been impacted by Coronavirus?

SPDR S&P Biotech ETF's stock was trading at $79.00 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, XBI stock has increased by 75.7% and is now trading at $138.77.
View which stocks have been most impacted by COVID-19.

Is SPDR S&P Biotech ETF a good dividend stock?

SPDR S&P Biotech ETF pays an annual dividend of $0.28 per share and currently has a dividend yield of 0.21%.
View SPDR S&P Biotech ETF's dividend history.

Who are SPDR S&P Biotech ETF's key executives?

SPDR S&P Biotech ETF's management team includes the following people:
  • James E. Ross, President, Trustee (Age 52)
  • Peter A. Ambrosini, Chief Compliance Officer (Age 69)
  • Michael P. Riley, Vice President (Age 44)
  • Gary L. French, Treasurer (Age 64)
  • John W. Clark, Assistant Treasurer (Age 46)
  • Matthew W. Flaherty, Assistant Treasurer (Age 42)
  • Chad C. Hallett, Assistant Treasurer of Street tracks series trust (Age 47)
  • Mary Moran Zeven, Secretary (Age 52)
  • Scott M. Zoltowski, Assistant Secretary (Age 44)
  • Dave Kelly, Independent Trustee

What other stocks do shareholders of SPDR S&P Biotech ETF own?

Based on aggregate information from My MarketBeat watchlists, some companies that other SPDR S&P Biotech ETF investors own include Intel (INTC), NVIDIA (NVDA), Pfizer (PFE), Gilead Sciences (GILD), iShares Nasdaq Biotechnology ETF (IBB), The Walt Disney (DIS), Micron Technology (MU), Cisco Systems (CSCO), AbbVie (ABBV) and Netflix (NFLX).

What is SPDR S&P Biotech ETF's stock symbol?

SPDR S&P Biotech ETF trades on the New York Stock Exchange (NYSE)ARCA under the ticker symbol "XBI."

Who are SPDR S&P Biotech ETF's major shareholders?

SPDR S&P Biotech ETF's stock is owned by a number of institutional and retail investors. Top institutional investors include Morgan Stanley (30.57%), Healthcare of Ontario Pension Plan Trust Fund (27.02%), Wells Fargo & Company MN (5.77%), JPMorgan Chase & Co. (1.91%), LPL Financial LLC (1.16%) and Bank Julius Baer & Co. Ltd Zurich (0.61%).

Which major investors are selling SPDR S&P Biotech ETF stock?

XBI stock was sold by a variety of institutional investors in the last quarter, including JPMorgan Chase & Co., Eaton Vance Management, Eaton Vance Management, Stifel Financial Corp, Trexquant Investment LP, Nan Shan Life Insurance Co. Ltd., Flagship Harbor Advisors LLC, and TrinityPoint Wealth LLC.

Which major investors are buying SPDR S&P Biotech ETF stock?

XBI stock was bought by a variety of institutional investors in the last quarter, including Healthcare of Ontario Pension Plan Trust Fund, Morgan Stanley, Wells Fargo & Company MN, Blair William & Co. IL, Cumberland Advisors Inc., LPL Financial LLC, Tompkins Financial Corp, and Tompkins Financial Corp.

How do I buy shares of SPDR S&P Biotech ETF?

Shares of XBI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is SPDR S&P Biotech ETF's stock price today?

One share of XBI stock can currently be purchased for approximately $138.77.

How much money does SPDR S&P Biotech ETF make?

SPDR S&P Biotech ETF has a market capitalization of $6.95 billion.

What is SPDR S&P Biotech ETF's official website?

The official website for SPDR S&P Biotech ETF is www.spdrs.com.

Where are SPDR S&P Biotech ETF's headquarters?

SPDR S&P Biotech ETF is headquartered at One Lincoln Street, Boston, 02111, United States.

How can I contact SPDR S&P Biotech ETF?

SPDR S&P Biotech ETF's mailing address is One Lincoln Street, Boston, 02111, United States. The exchange traded fund can be reached via phone at +1-866-7872257.


This page was last updated on 3/7/2021 by MarketBeat.com Staff
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.